Related references
Note: Only part of the references are listed.Hydroxychioroquine early n pregnancy and risk of birth defects
Krista F. Huybrechts et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2021)
Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reports
Adam Goldman et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Hydroxychloroquine Sulfate Related Hypoglycemia In A Non-Diabetic COVID-19 Patient: A Case Report and Literature Review
Narimana Imanova Yaghji et al.
POSTGRADUATE MEDICINE (2021)
American College of Rheumatology, American Academy of Dermatology, Rheumatologic Dermatology Society, and American Academy of Ophthalmology 2020 Joint Statement on Hydroxychloroquine Use With Respect to Retinal Toxicity
James T. Rosenbaum et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Cardiovascular Safety of Hydroxychloroquine in US Veterans With Rheumatoid Arthritis
Charles Faselis et al.
ARTHRITIS & RHEUMATOLOGY (2021)
2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases
Lisa R. Sammaritano et al.
ARTHRITIS CARE & RESEARCH (2020)
2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis
Antonis Fanouriakis et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
A rare cause of impaired general condition: Muscular and cardiac toxicity of antimalarials
T. Lenfant et al.
REVUE DE MEDECINE INTERNE (2020)
Hydroxychloroquine effects on psoriasis: A systematic review and a cautionary note for COVID-19 treatment
Muskaan Sachdeva et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive Mothers
Peter Izmirly et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
Antonis Fanouriakis et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Hydroxychloroquine treatment during pregnancy in lupus patients is associated with lower risk of preeclampsia
M. R. Seo et al.
LUPUS (2019)
Impact of tobacco smoking upon disease risk, activity and therapeutic response in systemic lupus erythematosus: A systematic review and meta-analysis
Dorian Parisis et al.
AUTOIMMUNITY REVIEWS (2019)
Breast milk concentration of hydroxychloroquine in Chinese lactating women with connective tissue diseases
Wenxiu Peng et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Risk of Ocular Anomalies in Children Exposed In Utero to Antimalarials: A Systematic Literature Review
Rouan Gaffar et al.
ARTHRITIS CARE & RESEARCH (2019)
Maternal outcomes and follow-up of preterm and term neonates born to mothers with systemic lupus erythematosus
Jae-Kyoon Hwang et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2018)
Prevalence of hydroxychloroquine-induced side-effects in dermatology patients: A retrospective survey of 102 patients
P. Tetu et al.
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE (2018)
Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature
Clotilde Chatre et al.
DRUG SAFETY (2018)
EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome
L. Andreoli et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Hydroxychloroquine Use in Lupus Patients during Pregnancy Is Associated with Longer Pregnancy Duration in Preterm Births
S. J. Kroese et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2017)
The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation
Carina Gotestam Skorpen et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Reproductive outcomes following hydroxychloroquine use for autoimmune diseases: a systematic review and meta-analysis
Yusuf Cem Kaplan et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
The effect of increasing the dose of hydroxychloroquine (HCQ) in patients with refractory cutaneous lupus erythematosus (CLE): An open-label prospective pilot study
Francois Chasset et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)
Breastfeeding in mothers with systemic lupus erythematosus
M. Noviani et al.
LUPUS (2016)
Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision)
Michael F. Marmor et al.
OPHTHALMOLOGY (2016)
Hydroxychloroquine as an anti-thrombotic in antiphospholipid syndrome
Cristina Belizna
AUTOIMMUNITY REVIEWS (2015)
Cutaneous Adverse Drug Reactions with Antimalarials and Allergological Skin Tests
Angele Soria et al.
DERMATOLOGY (2015)
Impact of hydroxychloroquine on preterm delivery and intrauterine growth restriction in pregnant women with systemic lupus erythematosus: a descriptive cohort study
M. Leroux et al.
LUPUS (2015)
Determinants of Hydroxychloroquine Blood Concentration Variations in Systemic Lupus Erythematosus
M. Jallouli et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Hydroxychloroquine: A multifaceted treatment in lupus
Nathalie Costedoat-Chalumeau et al.
PRESSE MEDICALE (2014)
Effects of biological and non-biological immunomodulatory therapies on the immunogenicity of vaccines in patients with rheumatic diseases
Zsuzsanna H. McMahan et al.
ARTHRITIS RESEARCH & THERAPY (2014)
The Risk of Toxic Retinopathy in Patients on Long-term Hydroxychloroquine Therapy
Ronald B. Melles et al.
JAMA OPHTHALMOLOGY (2014)
Hydroxychloroquine-Induced Pigmentation in Patients With Systemic Lupus Erythematosus A Case-Control Study
Moez Jallouli et al.
JAMA DERMATOLOGY (2013)
Maternal Use of Hydroxychloroquine Is Associated With a Reduced Risk of Recurrent Anti-SSA/Ro-Antibody-Associated Cardiac Manifestations of Neonatal Lupus
Peter M. Izmirly et al.
CIRCULATION (2012)
The association of systemic lupus erythematosus and myasthenia gravis: a series of 17 cases, with a special focus on hydroxychloroquine use and a review of the literature
M. Jallouli et al.
JOURNAL OF NEUROLOGY (2012)
Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine
Peter M. Izmirly et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Acute generalized exanthematous pustulosis and toxic epidermal necrolysis induced by hydroxychloroquine
Aisha Lateef et al.
CLINICAL RHEUMATOLOGY (2009)
Risk factors for acute generalized exanthematous pustulosis (AGEP) - results of a multinational case-control study (EuroSCAR)
A. Sidoroff et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment of systemic lupus erythematosus
Nathalie Costedoat-Chalumeau et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Heart conduction disorders related to antimalarials toxicity: an analysis of electrocardiograms in 85 patients treated with hydroxychloroquine for connective tissue diseases
N. Costedoat-Chalumeau et al.
RHEUMATOLOGY (2007)
Cardiomyopathy related to antimalarial therapy with illustrative case report
Nathalie Costedoat-Chalumeau et al.
CARDIOLOGY (2007)
Hydroxychloroquine in lupus pregnancy
Megan E. B. Clowse et al.
ARTHRITIS AND RHEUMATISM (2006)
Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus
Nathalie Costedoat-Chalumeau et al.
ARTHRITIS AND RHEUMATISM (2006)
Double-blind, randomized, controlled clinical trial of clofazimine compared with chloroquine in patients with systemic lupus erythematosus
ELM Bezerra et al.
ARTHRITIS AND RHEUMATISM (2005)
Safety of hydroxychloroquine in pregnant patients with connective tissue diseases - A study of one hundred thirty-three cases compared with a control group
N Costedoat-Chalumeau et al.
ARTHRITIS AND RHEUMATISM (2003)
Influence of hydroxychloroquine on the bioavailability of oral metoprolol
M Somer et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2000)
Share Paper
